|
|
|
 |
|
 |
Robert Benezra, Ph.D., Memorial Sloan-Kettering
Cancer Center, New York, professor, breast cancer research. Will
investigate if inhibition of Id, a novel angiogenesis inhibitor,
will lead to a novel cancer therapy |
|
|
 |
Diego Castrillon, M.D., Ph.D., University
of Texas Southwestern Medical Center, Dallas, assistant professor,
endometrial cancer research. Will examine the transcription family
called FoxO that are genetic switches controlling endometrial cell
growth and death |
|
|
 |
William Cliby, M.D., Mayo Clinic, Rochester,
Minn., associate professor, endometrial cancer research. ATR senses
DNA damage. Will test if mutations in ATR of patients with endometrial
cancer increases sensitivity to anti-cancer treatments |
|
|
 |
James
DiRenzo, Ph.D., Dartmouth Medical School, Hanover, N.H.,
assistant professor, breast cancer research. Will identify proteins
that interact with p63, a stem cell marker, that may be new targets
for cancer therapy |
|
|
 |
Suzanne Fuqua, Ph.D., Baylor
College of Medicine, Houston, professor, breast cancer research. To
understand tamoxifen toxicity and drug resistance in breast cancer |
|
|
 |
Theresa
Guise, M.D., University of Virginia, Charlottesville, professor,
breast cancer research. Will test agents that inhibit hypoxia-inducible
factor to slow or halt bone metastasis in breast cancer |
|
|
 |
Leaf Huang, Ph.D., University
of North Carolina at Chapel Hill, professor, cervical cancer research.
Will develop a vaccine against the viral cause of 90 percent of cervical
cancers, human papillomavirus |
|
|
 |
Michael
Ouellette, Ph.D., University of Nebraska Medical Center,
Omaha, assistant
professor, breast cancer research. Will test if blocking a newly identified
partner of telomerase, SAFB1, may be a novel approach to cancer therapy |
|
|
 |
Richard Roden, Ph.D., Johns
Hopkins School of Medicine, Baltimore, associate professor,
cervical cancer research. Will develop a vaccine against a different component
of papillomavirus |
|
|
 |
Toshiyasu
Taniguchi, M.D., Ph.D., Fred Hutchinson Cancer Research
Center, Seattle, assistant professor, ovarian cancer research.
Will study novel chemicals identified in a screen to determine
if they sensitize ovarian cancer cells to cisplatin (a drug used
widely in cancer therapy) |
|
|
|
|